Medical Health & Life Science Research News

New report shares details about the Global injectable drug delivery market forecasts to 2024

Medical Market Research

Global Injectable Drug Delivery Market, By Type (Devices {Conventional Injection, Self-Injection}, Formulations {Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations}, Applications, Usage Pattern, Mode of Administration, End User, Geography – Industry Trends and Forecast to 2024

Global Injectable Drug Delivery Market is expected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024. The upcoming market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request for Report @…_campaign=Shubham

The major factors driving the growth of this market are the increasing use of biologics, rising prevalence of chronic diseases, increasing occurrence of needle-stick injuries, and the benefits of injections (convenience, ease of use, and reduced pain). These factors increase the demand for devices such as safety syringes, prefilled syringes, and auto-disabled syringes.

On the other hand, safety concerns regarding the use of injectables, increased risk of blood-borne infections due to injectables, and presence of other drug delivery methods (such as oral and transdermal) may hinder the growth of the market.

The global injectable drug delivery market is segmented on the basis of type, product type, application, usage pattern, mode of administration, end user, distribution channel, and geography.

On the basis of product, global injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices.

The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.

Browse Full Report @…_campaign=Shubham

On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others. The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others.

Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others.

On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.

Request for TOC:…_campaign=Shubham

On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.

On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others. In 2017, the hospital &clinics segment is expected to dominate the market and is expected to continue this trend till 2024.

Based on geography the market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

In 2017, North America is expected to dominate the market.

The Global Injectable Drug Delivery Market Report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market. The report includes market shares of prefilled syringes market for global, Europe, North America, Asia Pacific and South America.

Access Report:…_campaign=Shubham

Some of the major players operating in this market are

  • Becton Dickinson and Company
  • Pfizer
  • Baxter International, Inc.
  • Gerresheimer AG
  • Schott AG
  • Alkermes Plc.
  • Eli Lilly and Company
  • Sandoz
  • Terumo Corporation
  • Teva Pharmaceuticals Industries Ltd.
  • Bespak
  • Antares Pharma
  • Elcam Medical
  • Haselmeier
  • Mylan N.V.
  • Novo Nordisk
  • Owen Mumford Ltd.
  • Sanofi
  • West Pharmaceutical Services, Inc.
  • Ypsomed Holding AG.

Inquire Report @…_campaign=Shubham

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany about: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
This email address is being protected from spambots. You need JavaScript enabled to view it.